Biopharma Boardroom speaks with Hubert Martens, CEO of Salvia BioElectronics, about the development of the MySalvia System, an investigational implantable neuromodulation therapy for people living with resistant migraine. Martens discusses the techno... Read more
As demand for Exatecan-based antibody-drug conjugates (ADCs) grows, securing reliable manufacturing capacity and diversified supply chains has become a priority for drug developers. Axplora is addressing these challenges through Axotecan, its initiat... Read more
Advanced Clinical, a global clinical research organization (CRO) providing full-service clinical development, functional service provider (FSP) solutions and strategic resourcing, has appointed John Cargill as Chief Commercial Officer (CCO). In his ... Read more
Managing motor fluctuations and dyskinesia remains a significant challenge for people living with advanced Parkinson's disease, despite advances in existing treatments. Lundbeck is seeking to address this unmet need with Lu AF28996, an investigationa... Read more
HCW Biologics Inc. (the “Company” or “HCW Biologics”), a U.S.-based clinical-stage biopharmaceutical company focused on developing novel fusion immunotherapeutics to treat autoimmune diseases, cancer, and senescence-associat... Read more
NanoImaging Services, a cryo-EM CRO, and Proteos, a protein production research partner, have announced the launch of TrueCourse Biosciences, an integrated CRO that brings together advanced capabilities to help pharmaceutical and biotechnolog... Read more
As cell and gene therapies progress towards broader commercialisation, scientific innovation alone is no longer enough. The next generation of therapies must be designed from the outset with potency, manufacturability, scalability, analytical... Read more
© 2026 Biopharma Boardroom. All Rights Reserved.
